v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Gross sales $ 2,152,268 $ 90,829
Discounts and allowances (239,457) (40,511)
Net sales 1,912,811 50,318
Cost of sales 818,051 6,357
Gross profit 1,094,760 43,961
Operating expenses:    
Selling and marketing 1,423,045 189,323
Research and development 788,888 1,054,310
General and administrative 5,911,725 3,715,340
Depreciation and amortization of intangible assets 78,675 83,486
Total operating expenses 8,202,333 5,042,459
Loss from operations (7,107,573) (4,998,498)
Other income (expense):    
Other income 168,146 44,798
Interest expense (18,214) (29,466)
Change in fair value of earnout liabilities 149,584 0
Inventory write-down (60,963) 0
Amortization of debt discount 0 (19,549)
Loss on forward purchase agreement 0 (5,700,451)
Loss on lease termination 0 (44,577)
Total other income (expense) 238,553 (5,749,245)
Loss from continuing operations before income taxes (6,869,020) (10,747,743)
Income tax expense (benefit) 36,262 (97,279)
Loss from continuing operations (6,905,282) (10,650,464)
Loss from discontinued operations, net of tax 0 (1,152,276)
Gain on sale of discontinued operations 0 1,434,479
Net loss $ (6,905,282) $ (10,368,261)
Basic    
Net loss from continuing operations - basic $ (4.83) $ (14.96)
Discontinued operations, net of tax - basic 0 0.4
Net loss per common share - basic (4.83) (14.56)
Diluted    
Net loss from continuing operations - diluted (4.83) (14.96)
Discontinued operations, net of tax - diluted 0 0.4
Net loss per common share - diluted $ (4.83) $ (14.56)
Weighted average of common shares outstanding , Basic 1,429,557 712,091
Weighted average of common shares outstanding, Diluted 1,429,557 712,091